key: cord-0873827-wsxvv09n
authors: Meyerowitz, Eric A.; Richterman, Aaron
title: SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
date: 2022-02-01
journal: Infect Dis Clin North Am
DOI: 10.1016/j.idc.2022.01.007
sha: f27af0847d4d3bc9a897584540fb6da317300efa
doc_id: 873827
cord_uid: wsxvv09n

The SARS-CoV-2 Delta variant transmits much more rapidly than prior SARS-CoV-2 viruses. The primary mode of transmission is via short range aerosols that are emitted from the respiratory tract of an index case. There is marked heterogeneity in the spread of this virus, with 10-20% of index cases contributing to 80% of secondary cases while most index cases have no subsequent transmissions. Vaccination, ventilation, masking, eye protection, and rapid case identification with contact tracing and isolation can all reduce transmission of this virus.

1. SARS-CoV-2 has an intense but discrete infectious period, from about 2 days before to about 5-7 days after the onset of symptoms. including masking, distancing, rapid case identification and contact tracing, and improved ventilation.

The modes of transmission of SARS-CoV-2 have been elucidated through detailed casecontact studies in a variety of contexts. While there was initial concern about the potential role of fomite or indirect transmission, this is not an important mechanism of spread of SARS-CoV-2, if it occurs at all. 1 Though SARS-CoV-2 remains viable for hours on contaminated surfaces under ideal experimental conditions, in real world settings replication competent virus is only rarely recovered from surfaces and then only at extremely low levels. [20] [21] [22] In the few case reports where fomite transmission has been suggested, respiratory transmission cannot be excluded. 1 Respiratory transmission, with SARS-CoV-2 carried on tiny particles emitted from the respiratory tract of an index case to a contact, is the clear and dominant route of spread. 1 From early in the pandemic, it has been evident that proximity is a key determinant of transmission risk. For instance, a contact tracing study of train passengers in China prior to universal masking that included 2,334 index cases and 72,093 close contacts found that the risk of transmission was directly related to distance between seats and amount of shared time on the train. 23 A detailed contact tracing study of the Diamond Princess cruise ship outbreak found that passengers with SARS-CoV-2 infection were either infected in shared public spaces in close contact or in their cabins when they were lodging with another infected passenger, but did not find evidence of transmissions between rooms. 24 In an outbreak of 14 confirmed and 6 probable cases on a plane in Japan, being seated within 2 rows of the index case was associated with an adjusted odds ratio for infection of 7.47 (95% CI: 2.06-27.2). 25 J o u r n a l P r e -p r o o f Before the COVID-19 pandemic, respiratory transmission of respiratory viruses and bacteria was widely categorized in a dichotomous way, with some pathogens, like tuberculosis, spread on smaller particles called aerosols and others spread on larger particles called droplets. [26] [27] [28] Pathogens spread on larger droplets were not thought to reach individuals more than about 6 feet away because they would fall to the ground due to gravitation effect, whereas smaller aerosols could remain suspended over longer distances and times. Designating a pathogen as droplet or aerosol spread implied the relative importance of different personal protective equipment (PPE), with surgical masks thought to suffice in the context of pathogens with droplet transmission ("droplet precautions") and respirators needed to prevent aerosol transmission ("airborne precautions"). Because proximity was so important and surgical masks reasonably effective at preventing spread (particularly in hospital settings), droplet spread within the traditional model was initially presumed to be the most important mechanism of transmission. 29, 30 However, it has become clear that the predominant mode of transmission of SARS-CoV-2 (as well as most other respiratory pathogens) is aerosol transmission, with short range aerosols the most important. 31 The risk of aerosol transmission is greatest at short range because the concentration, and therefore infectious dose, is highest there, whereas aerosols are diluted over larger distances. 32 Confusion about this topic has led some experts to call for a change in the terminology used to describe transmission of respiratory pathogens, and for a shift to focusing on "inhalation" as the major mode of transmission (Table 1) . 33 J o u r n a l P r e -p r o o f Surgical masks (especially when worn by source) provide some (but not complete) protection against aerosols. 35 There is a theoretical benefit to a respirator/N95, though the incremental benefit has not been clearly demonstrated in clinical trials or real-world studies to date

Not necessary for droplet spread; needed for aerosols or pathogens primarily transmitted via droplets when index cases undergo "aerosol generating procedures"

An important tool that can be used to decrease risk of most respiratory pathogens through dilutional mechanism J o u r n a l P r e -p r o o f

Evidence supporting the importance of aerosol transmission of SARS-CoV-2 includes numerous experimental and clinical studies. 31 For instance, a mathematical model showing the high risk associated with distances less than 6 feet, 36 a study showing that viral RNA was found in fine aerosols (particles ≤5um) 85% of the time rather than larger particles, 37 and real-world and experimental animal studies showing transmission is possible through the air at distances far greater than 6 feet. [38] [39] [40] In healthcare settings, there are now many well documented human-tohuman transmissions at distances greater than 6 feet, for instance in shared patient hospital rooms. 41 Longer range transmissions tend to occur in poorly ventilated settings, or when air flow is directed from an index case to secondary cases. 42, 43 In a very detailed description of an outbreak at a hospital in Boston, positive pressure of patient rooms relative to a nursing station on the unit was a proposed as a mechanism of spread beyond a patient room. 41 A detailed cluster report with sequencing of virus genomes at an isolation facility in New Zealand with closed circuit television monitoring found 3 linked secondary cases who were never in the same room, always >2 meters away from the index case, with aerosol transmission the only plausible mechanism of spread. 44, 45 As will be discussed later in this review, despite the overwhelming evidence for the predominance of aerosol transmission, the benefit of higher filtration masks over routine surgical masks in the community and in healthcare settings has yet to be conclusively demonstrated.

Host, virologic, and environmental factors all impact infectiousness of SARS-CoV-2. Apart from vaccination, which we discuss later in this review, the clearest host factor impacting transmission risk is whether the index case eventually develops symptoms. Several studies and systematic reviews have shown that persistently asymptomatic index cases are much J o u r n a l P r e -p r o o f less likely to lead to secondary cases compared to symptomatic index cases. For example, a household contact study from the original outbreak in Wuhan that included 27,101 affected households found that asymptomatic index cases were much less likely to transmit, with an adjusted odds ratio of 0.21 (95% CI: 0.14-0.31). 46 The respiratory tract viral load in the host at the time of an exposure is also clearly associated with infectiousness, with higher viral loads associated with greater likelihood of transmission. 49 In a pre-Delta era cohort study in Spain that included 282 index cases and 753 close contacts, secondary attack rate was directly related to the respiratory tract viral load of the index case at diagnosis. 50 A study of 1,058 students with SARS-CoV-2 infection at the University in Colorado, 860 of whom lived in multiple-occupancy rooms, found that the average viral load in the 116 index cases who transmitted to a roommate was 6.5 times higher compared to the 414 who did not. 51 Viral factors also impact infectiousness. As described previously, in vitro replication rate of Delta is higher than Alpha. 16 The Spike protein of Delta more efficiently binds to the host cell membrane ACE2 protein, which is the key host cell entry receptor. 59 This may correlate with significantly higher in vivo respiratory tract viral loads for Delta. In an outbreak of Delta in Guangdong province in China the peak viral load was much higher compared to the ancestral virus with a median peak cycle threshold of 20.6 for Delta infections versus 34.0 for a historical cohort (p<0.001). 60 While the increased transmissibility and fitness of Delta compared to prior variants is not disputed, studies have been mixed about whether peak viral load is in fact higher for Delta. [61] [62] [63] [64] [65] Additional mutations outside of the Spike region may enhance viral replication in other ways. Researchers showed that mutations in the nucleocapsid protein found in Delta and other more transmissible variants enhance mRNA delivery and packaging into virions and are associated with more rapid viral replication. 66 A number of environmental factors also predict the likelihood of transmission. The most important is ventilation, with outdoor transmission almost never identified. 1, 67 Indoor environments were noted to be important very early after the emergence of SARS-CoV-2 based on associations with clusters of transmission in Japan during its first wave. 68 Environmental J o u r n a l P r e -p r o o f factors like lower ambient temperatures and higher relative humidity may also be associated with increased transmission risk. 69 Socioeconomic deprivation has repeatedly been shown to be associated with increased risk for infection, likely because it is associated with increased probability of more frequent and higher risk exposures. [70] [71] [72] [73] [74] The Period of Infectiousness and Serial Interval:

A person with SARS-COV-2 infection has a discrete period of infectiousness that has been well defined for immunocompetent hosts. After an individual is exposed, there is an incubation period, defined as the time from exposure to symptom onset. Two key early papers examining the early cases in Wuhan, China in the pre-Delta era estimated the incubation period as 5.2 days (95% CI: 4.1-7.0) with 97.5% developing symptoms by 12.5 days (when reviewing the first 425 known cases) 75 and 5.1 days (95% CI: 4.5-5.8 days), with 97.5% developing symptoms by 11.5 days after exposure (for 181 cases with a known exposure and symptom onset), Figure 1 . 76 The incubation period for Delta appears to be significantly shorter than for prior SARS-CoV-2 viruses (Table 2) . 60 An analysis of 68 infections from 24 clusters from a contained Delta outbreak in Guangdong, China, found the mean incubation period was 4.4 days (95% CI: 3.9-5.0). 77 The incubation period for SARS-CoV-2, including the Delta variant, is significantly longer and more variable than the incubation period for influenza. In one example, the incubation period for pandemic H1N1 influenza A virus in 2009 was around 2 days with a standard deviation of about 2 days. 78 80 This is shorter than the mean latent period estimated in the pre-Delta period which was 5.5 days (95% CI: 5.1-5.9) with 95% of cases having detectable viral RNA by 10.6 days (95% CI: 9.6-11.6). 79 These viral characteristics lead to the observed serial interval, or the time between symptom onset in a primary and secondary case. A meta-analysis in the pre-Delta era estimated the serial interval as 5.4 (95% CI: 5.19-5.61). 81 Some studies have observed a shorter serial interval for Delta compared to earlier variants, 77, 80, 82 while others have not. 83 The long and variable incubation period and significant proportion of presymptomatic transmission make it difficult to estimate a mean serial interval for recently emerged variants, since it takes data from numerous well-defined transmission pairs to generate a reliable estimate. The degree to which a possible shorter serial interval contributes to the more rapid spread of Delta, which is also more transmissible than prior SARS-CoV-2 viruses (discussed in the next section), is not known at this time.

For those who develop symptoms, the infectious period begins before symptom onset, with presymptomatic transmission a major driver of the COVID-19 pandemic (Figure 1 Transmission risk is greater later in infection, after symptom onset for SARS-CoV-1 and MERS-CoV, making transmission mitigation of those infections easier than for SARS-CoV-2.

The basic reproductive number (R0) with implications for epidemic control. Heterogeneity is typically described using the dispersion parameter of a negative binomial distribution, or k. 100 (Figure 2 ). [105] [106] [107] [108] [109] [110] Despite the Delta variant's increased overall transmissibility, manifested by an increased R0, there is early evidence that transmission continues to display a similar degree of heterogeneity. 82, 111 Superspreading events continue to be identified in the Delta era, including in highly vaccinated populations. 112 While superspreading occurs for other highly transmissible respiratory pathogens like influenza and measles, it is J o u r n a l P r e -p r o o f generally thought to be less important as compared with SARS-CoV-2, with higher dispersion parameters for these other pathogens (see Table 4 ). 113 Note that increased overdispersion for measles has been reported in the post vaccination era, likely due to heterogeneity of susceptibility. 114, 115 Many factors can contribute to the likelihood of a superspreading event, including those related to the virus (e.g., timing relative to peak viral load), host (e.g., presence of symptoms), environment (e.g., ventilation, proximity), and behavior (e.g., singing, masking). 117 Transmission heterogeneity is also heavily driven by the concentration of exposure risk factors within specific networks, including among frontline and low-wage workers, and in congregate settings such as nursing homes, prisons, and homeless shelters. 118 The heterogeneity of transmission clusters can be visualized when transmission chains are depicted pictorially (Figure 3 ).

While superspreading events are rare, they make an outsized contribution to epidemic growth. As a result, public health interventions that reduce superspreading events (so-called "cutting the tail" interventions) can meaningfully reduce transmission, with modeling suggesting 49 While the exact amount of reduction varied by vaccine and transmission context, the overall protection against infection was at least 50%, and the reduction in transmission potential among the vaccinated relative to the unvaccinated was also 50% or greater, equivalent to an approximate transmission reduction of at least 75%. 49 In the Delta era, however, we must J o u r n a l P r e -p r o o f consider two additional factors that may influence the effects of vaccines on transmissionthe impact of the Delta Variant itself, and changes in immunity over time since vaccination.

When compared with Alpha, direct protection by the vaccines against symptomatic Delta infections appears to be modestly reduced by about 10-20%, with no change in relative protection against severe outcomes. 123 (Table 5 ). The reduction in transmission potential resulting from vaccination among people who become infected also appears to attenuate over time, as shown by the detailed contact tracing study of 108,498 index cases and 146,243 contacts in England. 133 This analysis found no transmission reduction at 12 weeks after vaccination for index cases vaccinated with ChAdOx1 (2%, 95% CI: -2-6%) and significantly attenuated reduction for those vaccinated with BNT162b2 (24%, 95% CI: 20-28%). This is further supported by virologic data from Israel,

where viral loads at diagnosis were found to be lower among vaccinated individuals with Delta infection within 2 months of vaccination relative to unvaccinated people, but that this difference disappeared by 6 months after vaccination. 138 In summary, the considerable indirect protection seen during the early months of the vaccine roll out, while still substantial in the Delta era, has likely been diminished to some extent because of a modest reduction in relative protection against infection and increased transmission potential of vaccinated individuals who become infected. The durable impact of booster doses on J o u r n a l P r e -p r o o f transmission remains to be seen, though they have shown early promise in short-term follow up. [138] [139] [140] [141] Transmission Prevention:

Extensive accumulated evidence supports multiple additional strategies for effective transmission prevention. Of note, most of the evidence supporting these strategies comes from the pre-Delta era. Besides vaccination, the other major tools to prevent transmission of SARS-CoV-2 include ventilation, physical distancing, rapid case-contact tracing and isolating, and effective personal protective equipment (PPE).

The role of improved ventilation in preventing transmission of SARS-CoV-2 has been shown in a variety of ways. In a crossover study looking at the effect of portal air/UV filtration devices in wards with patients with COVID-19, SARS-CoV-2 was detected in aerosols when the filters were not in use but not when the devices were turned on. 142 In a study of household transmission in China, opening a window to allow for better ventilation was associated with decreased infection risk. 143 In a study that included 169 primary schools in the state of Georgia, schools that had improved ventilation had a lower incidence of SARS-CoV-2 cases, with an adjusted relative risk of 0.61 (95% CI: 0.43-0.87). 144 Dilution methods alone, including opening doors and windows, or combining dilution with filtration (with installation of HEPA air filters)

were protective against incident SARS-CoV-2 infections. The importance of ventilation in decreasing transmission of respiratory pathogens was widely recognized even before the COVID-19 pandemic; for example, opening windows in hospitals and homes was found to provide excellent ventilation and educe tuberculosis transmission risk. 145, 146 The protective role of masking has been shown in multiple settings. In community settings, a large prospective cluster randomized controlled trial including nearly 350,000 people 150 Observational studies of mask mandate policies have also suggested a benefit to community masking. 151 A study comparing 15 counties in Kansas with a mask mandate to 68 counties without, found a mean 60% reduction in cases and hospitalizations and 65% reduction in deaths in counties with mask mandates. 152 These observational studies must be J o u r n a l P r e -p r o o f interpreted with caution because of secular trends and other policies that were concurrently implemented.

Universal masking in healthcare settings has also played an important role in reducing transmission in healthcare settings, which have the potential to be important sites of SARS-CoV-2 transmission. 30 30, 41, 160 However, a few cases of well documented transmission between a masked source patient and masked healthcare worker wearing eye protection have been described. 161 These cases seem to occur with prolonged exposure at close proximity with source patients with very high respiratory tract viral loads at the time of contact.

Rapid case identification and contact tracing with testing and isolation has been used to help control the COVID-19 pandemic. During the initial outbreak in South Korea, the roll out of rapid contact tracing with testing prior to symptom onset brought the effective reproductive number from 1.3 to 0.6 compared to the preceding period when testing was symptom driven. 162 In other pre-Delta study, the launch of an immediate trace and test program on the Isle of Wight in the UK was associated with a decrease in the reproductive number from 1.3 to 0.5. 163 This corroborates in vitro data showing substantially attenuated neutralization of Omicron with sera from vaccinated or convalesced individuals. 169, 170 Whether Omicron has intrinsically increased transmissibility over prior variants is unknown at this time.

Another characteristic feature of early Omicron outbreak reports is a shorter incubation period of about 3 days with very high rates of symptoms among vaccinated people. 171, 172 Viral J o u r n a l P r e -p r o o f load rises, peaks, and falls over a period of about 10 days, similar to findings from prior variants, with somewhat lower peak viral loads compared with Delta. 173, 174 Preliminary evidence from Japan suggests that peak viral load may occur 3-6 days after symptom onset, which may be later than was seen with prior variants. 175 Occasional long-range transmission continues to be documented along with superspreading events, though additional data are needed. 168, 171, 176 These preliminary reports suggest Omicron is more rapidly transmitted than Delta with a shorter incubation period and marked immune evasion that greatly increases risk of infection among vaccinated and recovered individuals. Very preliminary reports suggest that viral load may peak later for Omicron infections compared with those from prior variants. More data are needed to confirm these findings and to determine whether there are changes in the infectious period of each case and the exact degree of overdispersion characterizing transmission of Omicron.

The SARS-CoV-2 Delta variant transmits more rapidly and efficiently than prior SARS- 

Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

Spike mutation D614G alters SARS-CoV-2 fitness

SARS-CoV-2 spike D614G change enhances replication and transmission

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Decomposing the sources of SARS

CoV-2 fitness variation in the United States

SARS-CoV-2 mutations: the biological trackway towards viral fitness

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach

SARS-CoV-2 Variants in Patients with Immunosuppression

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Alpha Variant in a Japanese Population

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

SARS-CoV-2 Delta variant infects ACE2(low) primary human bronchial epithelial cells more efficiently than other variants

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi

Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

Fomites and the environment did not have an important role in COVID-19 transmission in a Brazilian mid-sized city

Longitudinal Monitoring of SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting

Risk of Coronavirus Disease 2019 Transmission in Train Passengers: an Epidemiological and Modeling Study

Lack of cross-transmission of SARS-CoV-2 between passenger's cabins on the Diamond Princess cruise ship

Transmission of SARS-CoV-2 during a 2-h domestic flight to Okinawa

How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve

What nobody needs to know about airborne infection

Ultraviolet irradiation of infected air: comparative infectiousness of different patients

Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence

Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health

Airborne transmission of respiratory viruses

Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs : A Narrative Review

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward

Poor ventilation worsens short-range airborne transmission of respiratory infection

Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance

Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2

The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center

Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea

COVID-19 Outbreak Associated with Air Conditioning in Restaurant

Airborne Transmission of SARS-CoV-2

Delta Variant within Tightly Monitored Isolation Facility

Transmission of Omicron (B.1.1.529) -SARS-CoV-2

Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. The Lancet Infectious diseases 2021

Indirect Protection by Reducing Transmission: Ending the Pandemic with SARS-CoV-2 Vaccination. Open Forum Infectious Diseases

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates

Transmission Risk, Viral Load, and Age: A Nationwide Study in Danish Households

Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States

On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community

Age-dependent effects in the transmission and control of COVID-19 epidemics

COVID-19 Outbreaks at Youth Summer Camps -Louisiana

2 (Delta) Variant in an Elementary School

Impact of Delta Variant and Vaccination on

Secondary Attack Rate Among Household Close Contacts

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases

Estimating infectiousness throughout SARS-CoV-2 infection course

Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant

Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles

Clusters of Coronavirus Disease in Communities

The transmission of SARS-CoV-2 is likely comodulated by temperature and by relative humidity

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy

Variation in SARS-CoV-2 Infection Risk and Socioeconomic Disadvantage Among a Mayan-Latinx Population in

Risk of Sars-CoV-2 infection and disease severity in people at socioeconomic disadvantage in Italy

Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity

Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Notes from the Field: Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 -Guangdong Province, China

Estimating time to onset of swine influenza symptoms after initial novel A(H1N1v) viral infection

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Transmission dynamics and epidemiological characteristics of Delta variant infections in China

Estimates of serial interval for COVID-19: A systematic review and meta-analysis

Transmission dynamics of the delta variant of SARS-CoV-2 infections in Daejeon, South Korea

Serial intervals in SARS-CoV-2 B.1.617.2 variant cases

Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason

Airborne SARS-CoV-2 in home-and hospital environment investigated with a high-powered air sampler

Complexity of the Basic Reproduction Number

Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence

Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout

Interim estimates of increased transmissibility, growth rate, and reproduction number of the Covid-19 B.1.617.2 variant of concern in the United Kingdom

Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. The Lancet Infectious diseases

Early epidemic dynamics of the west african 2014 ebola outbreak: estimates derived with a simple two-parameter model

Estimating the basic reproductive ratio for the Ebola outbreak in Liberia and Sierra Leone

Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility

Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies

Transmission dynamics and control of severe acute respiratory syndrome

The basic reproduction number (R(0)) of measles: a systematic review

Directly transmitted infections diseases: control by vaccination

Superspreading and the effect of individual variation on disease emergence

Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel

Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events

Coronavirus Disease Outbreak in Call Center

Large Outbreak of Coronavirus Disease among Wedding Attendees

High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice -Skagit County

SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp -Georgia

SARS-CoV-2 Infections and Serologic Responses from a Sample of

Serial interval and transmission dynamics during the SARS-CoV-2 Delta variant predominance in South Korea. medRxiv 2021: 2021

Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown

Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic. The Lancet Infectious diseases 2021

Estimating enhanced prevaccination measles transmission hotspots in the context of cross-scale dynamics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

Influenza transmission in households during the 1918 pandemic

Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2

Networks of SARS-CoV-2 transmission

Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Comparative systematic review and metaanalysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands

SARS-CoV-2 variants of concern and variants under investigation in England: Technical briefing 19

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance -Eight

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study

The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review

Despite Vaccination

Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

Covid-19 vaccination: evidence of waning immunity is overstated

Document FB. Vaccines and Related Biological Products Advisory Committee Meeting

Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

PFIZER AND BIONTECH ANNOUNCE PHASE 3 TRIAL DATA SHOWING HIGH EFFICACY OF A BOOSTER DOSE OF THEIR COVID-19 VACCINE

The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units

Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China

Mask Use and Ventilation Improvements to Reduce COVID-19 Incidence in Elementary Schools -Georgia

Natural ventilation for the prevention of airborne contagion

Natural ventilation reduces high TB transmission risk in traditional homes in rural

The Impact of Community Masking on COVID-19: A ClusterRandomized Trial in Bangladesh

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial

Face masks to prevent transmission of COVID-19: A systematic review and meta-analysis

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US

Association of Mask Mandates and COVID-19 Case Rates, Hospitalizations, and Deaths in Kansas

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center

Viral whole-genome sequencing to assess impact of universal masking on SARS-CoV-2 transmission among pediatric healthcare workers

Universal masking to control healthcareassociated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

A SARS-CoV-2 Cluster in an Acute Care Hospital

Characterising within-hospital SARS-CoV-2 transmission events: a retrospective analysis integrating epidemiological and viral genomic data from a UK tertiary care setting across two pandemic waves

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Asymptomatic and Presymptomatic Individuals in Healthcare Settings Despite Medical Masks and Eye Protection

Application of Testing-Tracing-Treatment Strategy in Response to the COVID-19 Outbreak in Seoul

Epidemiological changes on the Isle of Wight after the launch of the NHS Test and Trace programme: a preliminary analysis

Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study

Contact tracing efficiency, transmission heterogeneity, and accelerating COVID-19 epidemics

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Relative Instantaneous Reproduction Number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark

SARS-CoV-2 Omicron VOC Transmission in Danish Households

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway

Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers

Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant

Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron

Covid-19: Peak of viral shedding is later with omicron variant, Japanese data suggest

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel